Semaglutide mimics the release of GLP-1 (glucagon-like peptide-1), a hormone that signals the brain when you are full after eating
Semaglutide is administered by injection (or as an oral tablet that bypasses common food-drug absorption interactions), so it generally remains unaffected by milk or other foods in terms of absorption
Dependence of triagonist-enhanced glycaemic effects on TRPM5 function To confirm that the therapeutic effects of the triagonist depend on TRPM5 function, we assessed whether its beneficial effects were diminished in Trpm5 / mice
Madsbad S (2016): Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists
6 Given that elderly patients are at a higher risk for sarcopenia, it is essential to further investigate how Semaglutide treatment affects skeletal muscle in this population
Like GLP-1, it is also administered as a weekly injection and is approved for type 2 diabetes management, with promising results in weight loss trials